228 related articles for article (PubMed ID: 22355490)
21. [Successful resection of locally advanced gastrointestinal stromal tumor of the ampulla of Vater after treatment with imatinib].
Park JE; Dong SH; Cho KH; Jang JY; Kim HJ; Kim BH; Chang YW; Chang R
Korean J Gastroenterol; 2010 Jul; 56(1):39-44. PubMed ID: 20695129
[TBL] [Abstract][Full Text] [Related]
22. Advanced and Metastatic Gastrointestinal Stromal Tumors Presenting With Surgical Emergencies Managed With Surgical Resection: A Case Series.
Jayant D; Goyal M; Thakur V; Sahu S; Babu B; Subbiah Nagaraj S; Tandup C; Behera A
Cureus; 2024 Feb; 16(2):e53851. PubMed ID: 38465042
[TBL] [Abstract][Full Text] [Related]
23. A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome.
Zhu J; Yang Y; Zhou L; Jiang M; Hou M
BMC Cancer; 2010 May; 10():199. PubMed ID: 20465813
[TBL] [Abstract][Full Text] [Related]
24. State of the Art in the Treatment of Gastrointestinal Stromal Tumors.
Garlipp B; Bruns CJ
Gastrointest Tumors; 2014 May; 1(4):221-36. PubMed ID: 26672673
[TBL] [Abstract][Full Text] [Related]
25. Gastric GISTs. Personal experience.
Mingolla GP; Riccio PA; Linguerri R; La Donna M; Zannelli M; Artuso S
Ann Ital Chir; 2007; 78(4):283-8; discussion 288-9. PubMed ID: 17990602
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment.
Deshaies I; Cherenfant J; Gusani NJ; Jiang Y; Harvey HA; Kimchi ET; Kaifi JT; Staveley-O'Carroll KF
Ther Clin Risk Manag; 2010 Oct; 6():453-8. PubMed ID: 20957137
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal stromal tumors (GIST): a single center experience.
Kostka R; Gürlich R; Koldová L
Acta Chir Belg; 2012 Jan; 112(1):33-9. PubMed ID: 22442907
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal Stromal Tumours of the Rectum - Evaluating the National Registry Data with Respect to its Use in Clinical Practice.
Svatoň R; Kala Z; Kysela P; Procházka V; Eid M; Andrašina T; Poredská K; Strenková J; Chloupková R; Kunovsky L
Klin Onkol; 2019; 32(2):117-123. PubMed ID: 30995851
[TBL] [Abstract][Full Text] [Related]
29. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
Miettinen M; Majidi M; Lasota J
Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772
[TBL] [Abstract][Full Text] [Related]
30. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.
Gold JS; Dematteo RP
Ann Surg; 2006 Aug; 244(2):176-84. PubMed ID: 16858179
[TBL] [Abstract][Full Text] [Related]
31. Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.
Bauer S; Hartmann JT; de Wit M; Lang H; Grabellus F; Antoch G; Niebel W; Erhard J; Ebeling P; Zeth M; Taeger G; Seeber S; Flasshove M; Schütte J
Int J Cancer; 2005 Nov; 117(2):316-25. PubMed ID: 15900603
[TBL] [Abstract][Full Text] [Related]
32. Dramatic regression and bleeding of a duodenal GIST during preoperative imatinib therapy: case report and review.
Hecker A; Hecker B; Bassaly B; Hirschburger M; Schwandner T; Janssen H; Padberg W
World J Surg Oncol; 2010 Jun; 8():47. PubMed ID: 20515511
[TBL] [Abstract][Full Text] [Related]
33. Identification of Novel Imatinib-Resistant Genes in Gastrointestinal Stromal Tumors.
Cao L; Zheng K; Liu Y; Song P; Wang C; Wang H; Wang N; Zhang S; Zhao Y
Front Genet; 2022; 13():878145. PubMed ID: 35646090
[TBL] [Abstract][Full Text] [Related]
34. Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation.
Wilson J; Connock M; Song F; Yao G; Fry-Smith A; Raftery J; Peake D
Health Technol Assess; 2005 Jul; 9(25):1-142. PubMed ID: 15985189
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in the management of gastrointestinal stromal tumor.
Ahmed M
World J Clin Cases; 2020 Aug; 8(15):3142-3155. PubMed ID: 32874969
[TBL] [Abstract][Full Text] [Related]
36. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy.
Eisenberg BL; Judson I
Ann Surg Oncol; 2004 May; 11(5):465-75. PubMed ID: 15123459
[TBL] [Abstract][Full Text] [Related]
37. Recurrent Gastrointestinal Stromal Tumor With Chondroid Differentiation After Imatinib Therapy: An Unusual Case and Literature Review.
Le P; Monika F; Sabri A; Kovar J; Dietz N
Cureus; 2024 Feb; 16(2):e54842. PubMed ID: 38533168
[TBL] [Abstract][Full Text] [Related]
38. Targeting Disease Persistence in Gastrointestinal Stromal Tumors.
Ordog T; Zörnig M; Hayashi Y
Stem Cells Transl Med; 2015 Jul; 4(7):702-7. PubMed ID: 25934947
[TBL] [Abstract][Full Text] [Related]
39. Surgical intervention for imatinib and sunitinib-resistant gastrointestinal stromal tumors.
Kikuchi H; Setoguchi T; Miyazaki S; Yamamoto M; Ohta M; Kamiya K; Sakaguchi T; Konno H
Int J Clin Oncol; 2011 Dec; 16(6):741-5. PubMed ID: 21394667
[TBL] [Abstract][Full Text] [Related]
40. [Current aspects of treatment in gastrointestinal stromal tumors (GIST)].
Láng I; Hitre E
Orv Hetil; 2005 May; 146(18 Suppl 1):935-41. PubMed ID: 15921308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
